Cargando…
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium)
BACKGROUND: Although the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) causing coronavirus disease 2019 (COVID-19) primarily affects the respiratory system, the disease entity has been associated with cardiovascular complications. This study sought to assess the effect of concomitant...
Autores principales: | Koskinas, Konstantinos C., Twerenbold, Raphael, Carballo, David, Matter, Christian M., Cook, Stephane, Heg, Dik, Frenk, Andre, Windecker, Stephan, Osswald, Stefan, Lüscher, Thomas F., Mach, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613056/ https://www.ncbi.nlm.nih.gov/pubmed/37900573 http://dx.doi.org/10.3389/fcvm.2023.1203427 |
Ejemplares similares
-
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
por: Gencer, Baris, et al.
Publicado: (2017) -
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome
por: Canivell, Silvia, et al.
Publicado: (2018) -
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
por: Kuster, Gabriela M, et al.
Publicado: (2020) -
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction
por: Koskinas, Konstantinos C., et al.
Publicado: (2018) -
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
por: Carballo, David, et al.
Publicado: (2019)